+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Obesity Surgery Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 194 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968782
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The obesity surgery devices market is seeing rapid transformation, with strategic initiatives becoming essential as healthcare organizations respond to regulatory shifts, technology advancements, and evolving patient needs. In this environment, senior decision-makers require reliable insights to navigate emerging challenges and guide successful bariatric device operations.

Market Snapshot: Obesity Surgery Devices Market Overview

As of 2024, the global obesity surgery devices market holds a value of USD 4.39 billion, with forecasts projecting growth to USD 4.75 billion by 2025 and a projected CAGR of 8.15%. By 2032, industry expectations indicate market expansion to USD 8.22 billion, highlighting increasing demand for bariatric interventions, expanded access to funding, and ongoing technological innovation in medical devices. The evolution of regulatory standards and new models in care delivery are motivating healthcare organizations to refine their strategies and build operational resilience in the face of market complexity.

Scope & Segmentation: Strategic Structure for the Obesity Surgery Devices Market

Comprehensive segmentation within the obesity surgery devices sector enables targeted growth, informed investment, and tailored risk management for organizations planning to strengthen their market presence. Detailed awareness of segment dynamics supports allocation of resources and positions executive teams to capitalize on emerging opportunities across regions and technologies.

  • Procedure Types: Adjustable gastric banding, sleeve gastrectomy, and gastric bypass each address specific patient profiles and clinical workflows. Device configuration and selection depend on procedure-specific demands, shaping procurement and care pathways.
  • Device Types: Cutting tools, stapling systems, endoscopic suturing, implantable bands, access ports, and visualization instruments together comprise the essential toolkit for bariatric care, with each device type enhancing operating room safety and patient outcomes in distinct ways.
  • Technology Platforms: Adoption of open, laparoscopic, and robotic-assisted systems is redefining procedural efficiency and accuracy. The shift toward minimally invasive and digitally integrated platforms supports process standardization and expands the applicability of bariatric procedures across diverse hospital environments.
  • End Users: Hospitals, ambulatory surgery centers, public care organizations, and specialty clinics require device portfolios that match varying infrastructure capabilities and patient volumes. Understanding distinct end-user needs is pivotal for informed procurement and successful product implementation.
  • Regional Strategies: Effective entry and sustained growth depend on the ability to navigate regulatory and economic variations in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Regionally tailored approaches are necessary for optimizing market access and local adoption.
  • Leading Companies: Companies such as Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Intuitive Surgical, Stryker Corporation, Olympus Corporation, Smith & Nephew plc, CONMED Corporation, Boston Scientific Corporation, and Teleflex Incorporated drive the market through operational leadership, partnerships, and ongoing product innovation.

Key Takeaways for Senior Decision-Makers

  • Robotic and digitally enabled surgical platforms are changing clinical workflows, offering improved procedural consistency and operational efficiency across bariatric care settings.
  • Miniaturization and minimally invasive device trends facilitate quicker patient recovery and more flexible staffing, aligning with evolving expectations in patient care standards.
  • Artificial intelligence and intraoperative analytics are improving care coordination and reducing procedural risks, enabling higher procedural reliability and team performance during surgery.
  • Variability in reimbursement and care infrastructure across regions requires increased adaptability and locally informed strategies to mitigate external risks.
  • Collaboration between device manufacturers and digital health providers is fostering interoperable care models, which streamline processes and deliver efficiencies in bariatric management workflows.
  • Enhancing device workflow and supply chain integration is central to advancing sustainable quality outcomes and supporting operational targets in diverse care environments.

Tariff Impact: Supply Chain and Pricing Dynamics

Adjustments to U.S. import tariffs are influencing the pricing and sourcing of essential obesity surgery device components. Many industry participants are moving toward domestic and nearshore sourcing strategies to reduce dependence on extended supply chains and better manage procurement risks. Unified procurement practices and ongoing cost management are increasingly important to safeguard continuity of device supply and stabilize pricing within a shifting regulatory framework.

Methodology & Data Sources

The analysis combines data from peer-reviewed studies, industry patent filings, regulatory communications, and direct interviews with subject matter experts. Each conclusion is externally reviewed to offer accurate, actionable insights for strategic planning and executive decision-making.

Why This Report Matters

  • Equips executive teams with benchmarking intelligence and guidance for aligning operational initiatives with market dynamics in obesity surgery devices and bariatric care.
  • Delivers actionable foresight on technology and regulatory trends, reducing exposure to policy shifts and supporting prudent investment decisions in a competitive environment.
  • Facilitates compliance and organizational agility, helping stakeholders stay ahead of evolving healthcare regulations and models through market-driven intelligence.

Conclusion

This report provides leaders with the evidence-based insights needed to craft resilient strategies and proactively respond to continual changes in the obesity surgery devices market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increased adoption of robotic-assisted laparoscopic instruments for complex sleeve gastrectomy procedures
5.2. Development of bioresorbable gastric implants designed to minimize chronic foreign body reaction risks
5.3. Expansion of endoscopic transoral sleeve gastroplasty devices enabling outpatient weight loss interventions
5.4. Integration of sensor-enabled intragastric balloons for real-time monitoring of gastric pressure and volume
5.5. Emergence of dual-function intragastric balloons combining mechanical restriction with peptide hormone delivery capabilities
5.6. Adoption of 3D printing for patient-specific gastric bands and stents to optimize fit and reduce complication rates
5.7. Use of telehealth-connected wearable monitoring systems to track postoperative weight loss and nutritional compliance
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Obesity Surgery Devices Market, by Procedure Type
8.1. Adjustable Gastric Banding
8.2. Gastric Bypass
8.3. Sleeve Gastrectomy
9. Obesity Surgery Devices Market, by Device Type
9.1. Cutting And Stapling Devices
9.2. Endoscopic Devices
9.2.1. Stapling Devices
9.2.2. Suturing Devices
9.3. Implants
9.3.1. Band Systems
9.3.2. Port Systems
9.4. Visualization Systems
10. Obesity Surgery Devices Market, by Technology
10.1. Laparoscopic
10.2. Open
10.3. Robotic
10.3.1. Multi Arm
10.3.2. Single Port
11. Obesity Surgery Devices Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Specialty Clinics
12. Obesity Surgery Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Obesity Surgery Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Obesity Surgery Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Becton, Dickinson and Company
15.3.4. Intuitive Surgical, Inc.
15.3.5. Stryker Corporation
15.3.6. Olympus Corporation
15.3.7. Smith & Nephew plc
15.3.8. CONMED Corporation
15.3.9. Boston Scientific Corporation
15.3.10. Teleflex Incorporated

Companies Mentioned

The companies profiled in this Obesity Surgery Devices market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Becton, Dickinson and Company
  • Intuitive Surgical, Inc.
  • Stryker Corporation
  • Olympus Corporation
  • Smith & Nephew plc
  • CONMED Corporation
  • Boston Scientific Corporation
  • Teleflex Incorporated

Table Information